Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase

Multiple Comparisons Using Rank Sums

Dunn, O. J. (1964) · Technometrics · doi:10.1080/00401706.1964.10490181 · Cited by 5,168

Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.

Papapetropoulos, A., García‐Cardeña, G., Madri, J. A., & Sessa, W. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119868 · Cited by 1,195

Protein A, avidin, and biotin in immunohistochemistry.

Hsu, S. M., & Raine, L. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.11.6172466 · Cited by 638

Enzymes of Arginine Metabolism

Morris, S. M. (2004) · Journal of Nutrition · doi:10.1093/jn/134.10.2743s · Cited by 361

Incidence and distribution of argininosuccinate synthetase deficiency in human cancers

Dillon, B. J., Prieto, V. G., Curley, S. A., Ensor, M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2004) · Cancer · doi:10.1002/cncr.20057 · Cited by 317

Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.

Ensor, M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2002) · PubMed · Cited by 315

Nitric Oxide Mediates Interleukin-1-Induced Gene Expression of Matrix Metalloproteinases and Basic Fibroblast Growth Factor in Cultured Rabbit Articular Chondrocytes

Sasaki, K., Hattori, T., Fujisawa, T., Takahashi, K., Inoue, H., & Takigawa, M. (1998) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021955 · Cited by 272

Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies

Izzo, F., Marra, P., Beneduce, G., Castello, G., Vallone, P., De Rosa, V., Cremona, F., Ensor, C. M., Holtsberg, F. W., Bomalaski, J. S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.120 · Cited by 250

Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies

Ascierto, P. A., Scala, S., Castello, G., Daponte, A., Simeone, E., Ottaiano, A., Beneduce, G., De Rosa, V., Izzo, F., Melucci, M. T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0933 · Cited by 238

Relative importance of kidney and liver in synthesis of arginine by the rat

Featherston, W. R., Rogers, Q. R., & Freedland, R. (1973) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1973.224.1.127 · Cited by 186

The emerging hallmarks of cancer metabolism

Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926

Metabolic reprogramming in clear cell renal cell carcinoma

Wettersten, H. I., Aboud, O. A., Lara, P. N., & Weiss, R. H. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.59 · Cited by 587

Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer

Delage, B., Fennell, D. A., Nicholson, L., McNeish, I., Lemoine, N. R., Crook, T., & Szlosarek, P. W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25202 · Cited by 441

Myeloid Cell-Derived Arginase in Cancer Immune Response

Grzywa, T. M., Sosnowska, A., Matryba, P., Rydzyńska, Z., Jasiński, M., Nowis, D., & Gołąb, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00938 · Cited by 446

Arginine Deiminase as a Novel Therapy for Prostate Cancer Induces Autophagy and Caspase-Independent Apoptosis

Kim, R. H., Coates, J. M., Bowles, T. L., McNerney, G. P., Sutcliffe-Goulden, J., Jung, J. U., Gandour‐Edwards, R. F., Chuang, F. Y. S., Bold, R. J., & Kung, H.-J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3157 · Cited by 321

Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma

Lucarelli, G. T., Loizzo, D., Franzin, R., Battaglia, S., Ferro, M., Cantiello, F., Castellano, G., Bettocchi, C., Ditonno, P., & Battaglia, M. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1607729 · Cited by 249

Metabolic rearrangements in primary liver cancers: cause and consequences

Satriano, L., Lewińska, M., Rodrigues, P. M., Bañales, J. M., & Andersen, J. B. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0217-8 · Cited by 245

Arginine Deprivation as a Targeted Therapy for Cancer

Feun, L. G., You, M., Wu, C., Kuo, M. T., Wangpaichitr, M., Spector, S. A., & Savaraj, N. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784246199 · Cited by 236

Arginine Starvation Impairs Mitochondrial Respiratory Function in ASS1-Deficient Breast Cancer Cells

Qiu, F., Chen, Y.-R., Liu, X., Chu, C.-Y., Shen, L., Xu, J., Gaur, S., Forman, H. J., Zhang, H., Zheng, S. S., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2004761 · Cited by 221

Metabolic reprogramming in renal cancer: Events of a metabolic disease

Chakraborty, S., Balan, M., Sabarwal, A., Choueiri, T. K., & Pal, S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188559 · Cited by 214

IL‐8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer

Rotondo, R., Barisione, G., Mastracci, L., Grossi, F., Orengo, A. M., Costa, R., Truini, M., Fabbi, M., Ferrini, S., & Barbieri, O. (2009) · International Journal of Cancer · doi:10.1002/ijc.24448 · Cited by 198

Phase II Study of Pegylated Arginine Deiminase for Nonresectable and Metastatic Hepatocellular Carcinoma

Glazer, E. S., Piccirillo, M., Albino, V., Giacomo, R. D., Palaia, R., Mastro, A. A., Beneduce, G., Castello, G., Rosa, V. D., Petrillo, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7765 · Cited by 187

Oncometabolites: Unconventional triggers of oncogenic signalling cascades

Sciacovelli, M., & Frezza, C. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.025 · Cited by 184

Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma

Syed, N., Langer, J., Janczar, K., Singh, P., Nigro, C. L., Lattanzio, L., Coley, H. M., Hatzimichael, E. C., Bomalaski, J. S., Szlosarek, P. W., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2012.197 · Cited by 167

Targeting arginine metabolism pathway to treat arginine-dependent cancers

Qiu, F., Huang, J., & Sui, M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.020 · Cited by 158

Metabolic pathways of L-arginine and therapeutic consequences in tumors

Szefel, J., Danielak, A., & Kruszewski, W. J. (2018) · Advances in Medical Sciences · doi:10.1016/j.advms.2018.08.018 · Cited by 158

Arginine Metabolism in Bacterial Pathogenesis and Cancer Therapy

Xiong, L., Teng, J. L. L., Botelho, M. G., Lo, R. C., Lau, S. K. P., & Woo, P. C. Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030363 · Cited by 157

Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase

Bowles, T. L., Kim, R., Galante, J., Parsons, C. M., Virudachalam, S., Kung, H., & Bold, R. J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23723 · Cited by 153

Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma

Ott, P. A., Carvajal, R. D., Pandit-Taskar, N., Jungbluth, A. A., Hoffman, E. W., Wu, B.-W., Bomalaski, J. S., Venhaus, R., Pan, L., Old, L. J., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-012-9862-2 · Cited by 146

Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1α/Sp4

Tsai, W.-B., Aiba, I., Lee, S.-Y., Feun, L. G., Savaraj, N., & Kuo, M. T. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0794 · Cited by 143

Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer

Nicholson, L. J., Smith, P. R., Hiller, L., Szlosarek, P. W., Kimberley, C., Sehouli, J., Koensgen, D., Mustea, A., Schmid, P., & Crook, T. (2009) · International Journal of Cancer · doi:10.1002/ijc.24546 · Cited by 133

Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity

Ochocki, J. D., Khare, S., Hess, M., Ackerman, D., Qiu, B., Daisak, J. I., Worth, A. J., Lin, N., Lee, P., Xie, H. J., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.009 · Cited by 128

Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma

Kobayashi, E., Masuda, M., Nakayama, R. T., Ichikawa, H., Satow, R., Shitashige, M., Honda, K., Yamaguchi, U., Shoji, A., Tochigi, N., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0774 · Cited by 122

Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase

Kelly, M. P., Jungbluth, A. A., Wu, B.-W., Bomalaski, J. S., Old, L. J., & Ritter, G. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.524 · Cited by 117

Signaling, metabolism, and cancer: An important relationship for therapeutic intervention

Vaghari‐Tabari, M., Ferns, G. A., Qujeq, D., Andevari, A. N., Sabahi, Z., & Moein, S. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30276 · Cited by 126

Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase

Feun, L. G., Marini, A., Walker, G., Elgart, G., Moffat, F., Rodgers, S. E., Wu, C. J., You, M., Wangpaichitr, M., Kuo, M. T., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.106 · Cited by 113

Metabolomics and Metabolic Reprogramming in Kidney Cancer

Weiss, R. H. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.01.006 · Cited by 110

Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis

Lam, A. T., Wong, G., Chow, H., Chong, H.-C., Chow, T. L., Kwok, S.-Y., Cheng, P. N.-M., Wheatley, D. N., Lo, W., & Leung, Y. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00798.x · Cited by 99

The Relationship of Thioredoxin-1 and Cisplatin Resistance: Its Impact on ROS and Oxidative Metabolism in Lung Cancer Cells

Wangpaichitr, M., Sullivan, E. J., Theodoropoulos, G., Wu, C., You, M., Feun, L. G., Lampidis, T. J., Kuo, M. T., & Savaraj, N. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0599 · Cited by 94

Inhibition of arginase modulates T-cell response in the tumor microenvironment of lung carcinoma

Sosnowska, A., Chlebowska, J., Matryba, P., Pilch, Z., Greig, A., Wolny, A., Grzywa, T. M., Rydzyńska, Z., Sokołowska, O., Rygiel, T. P., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1956143 · Cited by 98

Amino acid deprivation using enzymes as a targeted therapy for cancer and viral infections

Fernandes, H. S., Teixeira, C. S. S., Fernandes, P. A., Ramos, M. J., & Cerqueira, N. M. F. S. A. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1254194 · Cited by 91

Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest

Lam, T. L., Wong, G., Chong, H.-C., Cheng, P. N.-M., Choi, S. C., Chow, T. L., Kwok, S.-Y., Poon, R. T. P., Wheatley, D. N., Lo, W., et al. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.11.031 · Cited by 87

Targeting extracellular nutrient dependencies of cancer cells

García‐Bermúdez, J., Williams, R. T., Guarecuco, R., & Birsoy, K. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.11.011 · Cited by 93

Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis‐Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment

Zhi, Y., Wang, Q., Zi, M., Zhang, S., Ge, J., Liu, K., Lu, L., Fan, C., Yan, Q., Shi, L., et al. (2024) · Advanced Science · doi:10.1002/advs.202306515 · Cited by 99

Overexpression of Arginine Transporter CAT-1 Is Associated with Accumulation of L-Arginine and Cell Growth in Human Colorectal Cancer Tissue

Lü, Y., Wang, W., Wang, J., Yang, C., Mao, H.-M., Fu, X., Wu, Y., Cai, J., Han, J., Xu, Z., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073866 · Cited by 81

Novel drugs that target the metabolic reprogramming in renal cell cancer

van der Mijn, J. C., Panka, D. J., Geissler, A. K., Verheul, H. M. W., & Mier, J. W. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0154-8 · Cited by 83

Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma

Yau, T. C. C., Cheng, P., Chan, P., Chen, L., Yuen, J. H. F., Pang, R. W. C., Fan, S. T., Wheatley, D. N., & Poon, R. T. P. (2015) · Investigational New Drugs · doi:10.1007/s10637-014-0200-8 · Cited by 79

Discriminating gastric cancer and gastric ulcer using human plasma amino acid metabolic profile

Jing, F., Hu, X., Cao, Y., Xu, M., Wang, Y., Jing, Y., Hu, X., Gao, Y., & Zhu, Z. (2018) · IUBMB Life · doi:10.1002/iub.1748 · Cited by 72

Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy

McAlpine, J. A., Lu, H.-T., Wu, K. C., Knowles, S. K., & Thomson, J. A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-621 · Cited by 67

Arginine Starvation and Docetaxel Induce c-Myc–Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors

Prudner, B. C., Rathore, R., Robinson, A. M., Godec, A., Chang, S. F., Hawkins, W. G., Hirbe, A. C., & Tine, B. A. V. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0206 · Cited by 66

Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells

Khoury, O., Ghazale, N., Stone, E. M., El‐Sibai, M., Frankel, A. E., & Abi‐Habib, R. J. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1698-5 · Cited by 64

Aspergillus nidulans thermostable arginine deiminase-Dextran conjugates with enhanced molecular stability, proteolytic resistance, pharmacokinetic properties and anticancer activity

El‐Sayed, A. S. A., Shindia, A. A., Abou-Zeid, A. A., Yassin, A. M., Sitohy, M. Z., & Sitohy, B. (2019) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2019.109432 · Cited by 61

SCHEMA-Designed Variants of Human Arginase I and II Reveal Sequence Elements Important to Stability and Catalysis

Romero, P. A., Stone, E. M., Lamb, C., Chantranupong, L., Krause, A., Miklos, A. E., Hughes, R. A., Fechtel, B. M., Ellington, A. D., Arnold, F. H., et al. (2012) · ACS Synthetic Biology · doi:10.1021/sb300014t · Cited by 60

Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM

Przystal, J. M., Hajji, N., Khozoie, C., Renziehausen, A., Zeng, Q., Abaitua, F., Hajitou, A., Suwan, K., Want, E. J., Bomalaski, J. S., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1195-4 · Cited by 57

Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells

Tanios, R. F., Bekdash, A., Kassab, E., Stone, E. M., Georgiou, G., Frankel, A. E., & Abi‐Habib, R. J. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.08.007 · Cited by 55

Effect of arginase II on L-arginine depletion and cell growth in murine cell lines of renal cell carcinoma

Tate, D. J., Vonderhaar, D. J., Caldas, Y. A., Metoyer, T., Patterson, J. R., Avilés, D., & Zea, A. H. (2008) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-1-14 · Cited by 56

Metabolic alterations in hereditary and sporadic renal cell carcinoma

Coffey, N. J., & Simon, M. C. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00800-2 · Cited by 56

The arginine metabolism and its deprivation in cancer therapy

Feng, T., Xie, F., Lyu, Y., Yu, P., Chen, B., Yu, J., Zhang, G., To, K. F., Tsang, C. M., & Kang, W. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217680 · Cited by 54

Arginine reprogramming in ADPKD results in arginine-dependent cystogenesis

Trott, J. F., Hwang, V. J., Ishimaru, T., Chmiel, K. J., Zhou, J. X., Shim, K., Stewart, B. J., Mahjoub, M. R., Jen, K., Barupal, D. K., et al. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00025.2018 · Cited by 52

Arginine deprivation therapy for malignant melanoma

Kim, K., Yoon, Y., Frankel, A. E., Feun, & Ekmekcioglu (2012) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s37350 · Cited by 50

Arginine deprivation affects glioblastoma cell adhesion, invasiveness and actin cytoskeleton organization by impairment of β-actin arginylation

Pavlyk, I., Rzhepetskyy, Y., Jagielski, A. K., Drożak, J., Wasik, A., Pereverzieva, G., Brewińska‐Olchowik, M., Kunz‐Schughart, L. A., Stasyk, O. V., & Rędowicz, M. J. (2014) · Amino Acids · doi:10.1007/s00726-014-1857-1 · Cited by 50

Amino Acid Degrading Enzymes and their Application in Cancer Therapy

Pokrovsky, V. S., Chepikova, O. E., Давыдов, Д. Ж., Zamyatnin, A. A., Lukashev, A. N., & Lukasheva, E. V. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666171006132729 · Cited by 50

Single amino acid arginine starvation efficiently sensitizes cancer cells to canavanine treatment and irradiation

Vynnytska‐Myronovska, B., Bobak, Y. P., Garbe, Y., Dittfeld, C., Stasyk, O. V., & Kunz‐Schughart, L. A. (2011) · International Journal of Cancer · doi:10.1002/ijc.26221 · Cited by 48

A cluster of long non-coding RNAs exhibit diagnostic and prognostic values in renal cell carcinoma

Cheng, G., Liu, D., Liang, H., Yang, H., Chen, K., & Zhang, X. (2019) · Aging · doi:10.18632/aging.102407 · Cited by 47

Amino Acids in Cancer and Cachexia: An Integrated View

Ragni, M., Fornelli, C., Nisoli, E., & Penna, F. (2022) · Cancers · doi:10.3390/cancers14225691 · Cited by 48

Argininosuccinate lyase is a potential therapeutic target in breast cancer

Huang, H.-L., Chen, W.-C., Hsu, H., Cho, C.-Y., Hung, Y.-H., Wang, C., & Lai, M.-D. (2015) · Oncology Reports · doi:10.3892/or.2015.4280 · Cited by 49

Prevention and treatment of cancers by immune modulating nutrients

Janakiram, N. B., Mohammed, A., Madka, V., Kumar, G., & Rao, C. V. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500884 · Cited by 48

Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent

Nasreddine, G., El‐Sibai, M., & Abi‐Habib, R. J. (2019) · Investigational New Drugs · doi:10.1007/s10637-019-00756-w · Cited by 46

The role of arginine and the modified arginine deiminase enzyme ADI-PEG 20 in cancer therapy with special emphasis on Phase I/II clinical trials

Synakiewicz, A., Stachowicz‐Stencel, T., & Adamkiewicz‐Drożyńska, E. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.934808 · Cited by 45

The Immune Microenvironment in Penile Cancer and Rationale for Immunotherapy

Ahmed, M. E., Falasiri, S. S. A., Hajiran, A. J., Chahoud, J., & Spiess, P. E. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103334 · Cited by 45

Pegylated arginine deiminase synergistically increases the cytotoxicity of gemcitabine in human pancreatic cancer

Daylami, R., Muilenburg, D. J., Virudachalam, S., & Bold, R. J. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/preaccept-8245834981349245 · Cited by 43

Unlocking the Potential of Arginine Deprivation Therapy: Recent Breakthroughs and Promising Future for Cancer Treatment

Chu, Y., Lai, M., & Yeh, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310668 · Cited by 44

Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling

Liu, J., Ma, J., Wu, Z., Li, W., Zhang, D., Han, L., Wang, F., Reindl, K. M., Wu, E., & Ma, Q. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-686 · Cited by 41

Arginine deprivation as a new treatment strategy for head and neck cancer

Huang, C., Tsai, S., Kuo, C., Chang, J. S.-M., Jin, Y., Chang, J., & Hsiao, J. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.06.004 · Cited by 41

Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine deiminase (ADI-PEG20)

Burrows, N., Cane, G., Robson, M. P., Gaude, E., Howat, W., Szlosarek, P. W., Pedley, R. B., Frezza, C., Ashcroft, M. A., & Maxwell, P. H. (2016) · Scientific Reports · doi:10.1038/srep22950 · Cited by 39

Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics

Wang, Y., Liu, X., Gong, L., Ding, W., Hao, W., Peng, Y., Zhang, J., Cai, W., & Gao, Y. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16252 · Cited by 37

Attenuation of Argininosuccinate Lyase Inhibits Cancer Growth via Cyclin A2 and Nitric Oxide

Huang, H.-L., Hsu, H., Shieh, S.-C., Chang, Y.-S., Chen, W.-C., Cho, C.-Y., Teng, C., Su, I., Hung, W.-C., & Lai, M.-D. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0863 · Cited by 37

Mechanism‐based treatment of cancer with immune checkpoint inhibitor therapies

Abdou, Y. G., Pandey, M. R., Sarma, M., Shah, S., Baron, J. I., & Ernstoff, M. S. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14316 · Cited by 35

Bacterial proteins as potential drugs in the treatment of leukemia

Kwan, J. M., Fialho, A. M., Kundu, M., Thomas, J., Hong, C. S., Gupta, T. K. D., & Chakrabarty, A. M. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.01.024 · Cited by 36

Up-Regulation of NMRK2 Mediated by TFE3 Fusions is the Key for Energy Metabolism Adaption of Xp11.2 Translocation Renal Cell Carcinoma

Chen, Y., Yang, L., Lu, Y., Liu, N., Ma, W., Fan, H., Hu, Q., Han, X., Gan, W., & Li, D. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215689 · Cited by 34

Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma

Liu, Q., Stewart, J., Wang, H., Rashid, A., Zhao, J., Katz, M. H. G., Lee, J. E., Fleming, J. B., Maitra, A., Wolff, R. A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171985 · Cited by 34

Preclinical safety and antitumor activity of the arginine-degrading therapeutic enzyme pegzilarginase, a PEGylated, cobalt-substituted recombinant human arginase 1

Agnello, G., Alters, S. E., & Rowlinson, S. W. (2019) · Translational research · doi:10.1016/j.trsl.2019.12.005 · Cited by 34

A Potential Antitumor Drug (Arginine Deiminase) Reengineered for Efficient Operation under Physiological Conditions

Zhu, L., Verma, R., Roccatano, D., Ni, Y., Sun, Z., & Schwaneberg, U. (2010) · ChemBioChem · doi:10.1002/cbic.201000458 · Cited by 33

Analysis of Gene Expression Identifies Differentially Expressed Genes and Pathways Associated with Lymphatic Dissemination in Patients with Adenocarcinoma of the Esophagus

Lagarde, S. M., van Themaat, P. E. V. L., Moerland, P. D., Gilhuijs-Pederson, L. A., ten Kate, F. J. W., Reitsma, P. H., van Kampen, A. H. C., Zwinderman, A. H., Baas, F., & van Lanschot, J. J. B. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0165-y · Cited by 33

The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma

Thongkum, A., Wu, C., Li, Y.-Y., Wangpaichitr, M., Navasumrit, P., Parnlob, V., Sricharunrat, T., Bhudhisawasdi, V., Ruchirawat, M., & Savaraj, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061175 · Cited by 33

The relationship of arginine deprivation, argininosuccinate synthetase and cell death in melanoma.

Savaraj, N., Wu, C., Kuo, M. T., You, M., Wangpaichitr, M., Robles, C., Spector, S. A., & Feun, L. G. (2007) · Europe PMC (PubMed Central) · Cited by 32

Arginase purified from endophytic Pseudomonas aeruginosa IH2: Induce apoptosis through both cell cycle arrest and MMP loss in human leukemic HL-60 cells

Husain, I., Bala, K., Wani, A., Makhdoomi, U. S., Malik, F. A., & Sharma, A. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.07.001 · Cited by 31

Simultaneous determination of l-citrulline and l-arginine in plasma by high performance liquid chromatography

Mao, H.-M., Wei, W., Xiong, W., Lü, Y., Chen, B.-G., & Liu, Z. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.05.017 · Cited by 31

Arginine depriving enzymes: applications as emerging therapeutics in cancer treatment

Kumari, N., & Bansal, S. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-021-04335-w · Cited by 30

The Relationship of Arginine Deprivation, Argininosuccinate Synthetase and Cell Death in Melanoma

Savaraj, N., Wu, C., Kuo, M. T., You, M., Wangpaichitr, M., Robles, C., Spector, S. A., & Feun, L. G. (2007) · Drug Target Insights · doi:10.1177/117739280700200016 · Cited by 30

Improved method for expression and isolation of the Mycoplasma hominis arginine deiminase from the recombinant strain of Escherichia coli

Fayura, L. R., Boretsky, Y. R., Pynyaha, Y. V., Wheatley, D. N., & Sibirny, A. А. (2013) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2013.06.025 · Cited by 29

Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapy

Stone, E. M., Chantranupong, L., Gonzalez, C., O’Neal, J. F., Rani, M., Berg, C. L. V. D., & Georgiou, G. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.097 · Cited by 28

Single Amino Acid Arginine Deprivation Triggers Prosurvival Autophagic Response in Ovarian Carcinoma SKOV3

Shuvayeva, G., Bobak, Y. P., Igumentseva, N. I., Titone, R., Morani, F., Stasyk, O. V., & Isidoro, C. (2014) · BioMed Research International · doi:10.1155/2014/505041 · Cited by 27

[HuArgI (co)-PEG5000]-induced arginine deprivation leads to autophagy dependent cell death in pancreatic cancer cells

Khalil, N., & Abi‐Habib, R. J. (2019) · Investigational New Drugs · doi:10.1007/s10637-019-00883-4 · Cited by 27

Treating liver cancer through arginine depletion

Prasad, Y. R., Anakha, J., & Pande, A. H. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103940 · Cited by 27

Snail enhances arginine synthesis by inhibiting ubiquitination-mediated degradation of ASS1

Jia, H., Yang, Y., Li, M., Chu, Y., Song, H., Zhang, J., Zhang, D., Zhang, Q., Xu, Y., Wang, J., et al. (2021) · EMBO Reports · doi:10.15252/embr.202051780 · Cited by 23

Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas

Cheon, D., Walts, A. E., Beach, J. A., Lester, J., Bomalaski, J. S., Walsh, C., Wiedemeyer, W. R., Karlan, B. Y., & Oršulić, S. (2014) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.4 · Cited by 24

Protein Engineering of the Antitumor Enzyme PpADI for Improved Thermal Resistance

Zhu, L., Cheng, F., Piatkowski, V., & Schwaneberg, U. (2013) · ChemBioChem · doi:10.1002/cbic.201300433 · Cited by 23

Antitumor Activity of Arsenic Trioxide on Retinoblastoma: Cell Differentiation and Apoptosis Depending on Arsenic Trioxide Concentration

Kim, J. H., Kim, J. H., Yu, Y. S., Kim, D. H., Kim, C. J., & Kim, K. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2623 · Cited by 21

Changes in arginase isoenzymes pattern in human hepatocellular carcinoma

Chrzanowska, A., Krawczyk, M., & Barańczyk‐Kuźma, A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.093 · Cited by 21

Activation of autophagy following [HuArgI (Co)-PEG5000]-induced arginine deprivation mediates cell death in colon cancer cells

Swayden, M., Bekdash, A., Fakhoury, I., Atat, O. E., Borjac, J., El‐Sibai, M., & Abi‐Habib, R. J. (2020) · Human Cell · doi:10.1007/s13577-020-00437-4 · Cited by 19

Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability

Abbott, K. L., Ali, A., Reinfeld, B. I., Deik, A., Subudhi, S., Landis, M. D., Hongo, R. A., Young, K. L., Kunchok, T., Nabel, C. S., et al. (2024) · eLife · doi:10.7554/elife.95652 · Cited by 22

Novel Mechanistic Insights into Arginine Deiminase Pharmacology Suggest 18F-FDG Is Not Suitable to Evaluate Clinical Response in Melanoma

Stelter, L., Evans, M. J., Jungbluth, A. A., ZANZONICO, P. B., Ritter, G., Ku, T. W., Rosenfeld, E., Bomalaski, J. S., Old, L. J., & Larson, S. M. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.092973 · Cited by 18

An eleven metabolic gene signature-based prognostic model for clear cell renal cell carcinoma

Wu, Y., Wei, X., Feng, H., Hu, B., Liu, B., Luan, Y., Ruan, Y., Liu, X., Liu, Z., Wang, S., et al. (2020) · Aging · doi:10.18632/aging.104088 · Cited by 18

Three-dimensional environment renders cancer cells profoundly less susceptible to a single amino acid starvation

Vynnytska‐Myronovska, B., Kurlishchuk, Y. V., Bobak, Y. P., Dittfeld, C., Kunz‐Schughart, L. A., & Stasyk, O. V. (2013) · Amino Acids · doi:10.1007/s00726-013-1586-x · Cited by 18

Predictive markers for efficiency of the amino-acid deprivation therapies in cancer

Pokrovsky, V. S., Qoura, L. A., Morozova, E. A., & Bunik, V. I. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1035356 · Cited by 17

Arginine Is a Novel Drug Target for Arginine Decarboxylase in Human Colorectal Cancer Cells

Wei, X., Chow, H., Chong, H.-C., Leung, S.-L., Ho, M.-K., Lee, L. M.-Y., & Leung, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813741 · Cited by 18

Combined lysosomal protein transmembrane 4 beta-35 and argininosuccinate synthetase expression predicts clinical outcome in hepatocellular carcinoma patients

Yang, H., Lin, M. T., Xiong, F., Yang, Y., Nie, X., McNutt, M. A., & Zhou, R. (2011) · Surgery Today · doi:10.1007/s00595-010-4338-5 · Cited by 17

Structural and Functional Insights into the Regulation ofHelicobacter pyloriArginase Activity by an Evolutionary Nonconserved Motif

Srivastava, A., Meena, S. K., Alam, M., Nayeem, S. M., Deep, S., & Sau, A. K. (2012) · Biochemistry · doi:10.1021/bi301421v · Cited by 17

Arginine Deiminase Enhances MCF-7 Cell Radiosensitivity by Inducing Changes in the Expression of Cell Cycle-related Proteins

Park, H., Lee, J., Shim, Y.-J., Shin, Y., Jeong, S.-Y., Oh, J., Park, G. H., Lee, K.-H., & Min, B.-H. (2008) · Molecules and Cells · doi:10.1016/s1016-8478(23)17586-8 · Cited by 17

Abstract 2702: Renal cell carcinomas lack arginosuccinate synthetase expression and respond to pegylated arginine deiminase treatment

He, W., Chen, J., Zheng, Y., Dai, Z., He, Y., Wu, B.-W., & Bomalaski, J. S. (2010) · Cancer Research · doi:10.1158/1538-7445.am10-2702

Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase

Bowles, T. L., Kim, R., Galante, J., Parsons, C. M., Virudachalam, S., Kung, H., & Bold, R. J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23723 · Cited by 153

Arginine Deprivation as a Targeted Therapy for Cancer

Feun, L. G., You, M., Wu, C., Kuo, M. T., Wangpaichitr, M., Spector, S. A., & Savaraj, N. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784246199 · Cited by 236

Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase

Kelly, M. P., Jungbluth, A. A., Wu, B.-W., Bomalaski, J. S., Old, L. J., & Ritter, G. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.524 · Cited by 117

Pegylated Recombinant Human Arginase (rhArg-peg5,000mw) Inhibits the In vitro and In vivo Proliferation of Human Hepatocellular Carcinoma through Arginine Depletion

Cheng, P., Lam, T. L., Lam, W.-M., Tsui, S. M., Cheng, A. W. M., Lo, W. H., & Leung, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1945 · Cited by 280